Name | Description | SBIR/STTR Award Recipient | Government Agency | Government Branch | Award Type | Contract Number (US Government) | Award Phase | Award Amount (USD) | Date Awarded | Official Website | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|
A SBIR Phase II contract was awarded to Stem Pharm in August, 2020 for $1,546,685.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health. | SBIR | 2R44NS102088-02A1 | Phase II | 1,546,685 | August 15, 2020 | |||||||
A SBIR Phase I contract was awarded to Stem Pharm in September, 2018 for $280,000.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health. | SBIR | 1R43ES029897-01 | Phase I | 280,000 | September 1, 2018 | |||||||
A SBIR Phase II contract was awarded to Stem Pharm in March, 2021 for $930,433.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health. | SBIR | 2R44ES029898-02A1 | Phase II | 930,433 | March 18, 2021 | |||||||
A SBIR Phase I contract was awarded to Stem Pharm in May, 2019 for $225,000.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health. | SBIR | 1R43ES029898-01A1 | Phase I | 225,000 | May 15, 2019 | |||||||
A SBIR Phase I contract was awarded to Stem Pharm in September, 2018 for $224,976.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health. | SBIR | 1R43NS102088-01A1 | Phase I | 224,976 | September 15, 2018 | |||||||
A SBIR Phase I contract was awarded to Stem Pharm in September, 2023 for $499,903.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health. | SBIR | 1R43AG082625-01A1 | Phase I | 499,903 | September 1, 2023 | |||||||
A STTR Phase I contract was awarded to Stem Pharm in July, 2023 for $406,500.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health. | STTR | 1R41CA281533-01A1 | Phase I | 406,500 | July 11, 2023 |